Literature DB >> 19805634

A novel measurement index for antihypertensive medication burden and its use.

Siu-Hin Wan, Meaghan Hart, Ihab Hajjar.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19805634     DOI： 10.1161/HYPERTENSIONAHA.109.140681

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  7 in total

Review 1.  Deprescribing in Older Nursing Home Patients: Focus on Innovative Composite Measures for Dosage Deintensification.

Authors:  Sherrie L Aspinall; Joseph T Hanlon; Joshua D Niznik; Sydney P Springer; Carolyn T Thorpe
Journal:  Innov Aging       Date:  2017-12-20

2.  Antihypertensive drug class use and differential risk of urinary incontinence in community-dwelling older women.

Authors:  Emily P Peron; Yan Zheng; Subashan Perera; Anne B Newman; Neil M Resnick; Ronald I Shorr; Douglas C Bauer; Eleanor M Simonsick; Shelly L Gray; Joseph T Hanlon; Christine M Ruby
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-09-12       Impact factor: 6.053

3.  Safety and blood pressure trajectory of short-term withdrawal of antihypertensive medications in older adults: experience from a clinical trial sample.

Authors:  Ihab Hajjar; Meaghan Hart; Siu-Hin Wan; Vera Novak
Journal:  J Am Soc Hypertens       Date:  2013-05-13

4.  Effect of Low-Sodium versus Conventional Sodium Dialysate on Left Ventricular Mass in Home and Self-Care Satellite Facility Hemodialysis Patients: A Randomized Clinical Trial.

Authors:  Mark R Marshall; Alain C Vandal; Janak R de Zoysa; Ruvin S Gabriel; Imad A Haloob; Christopher J Hood; John H Irvine; Philip J Matheson; David O R McGregor; Kannaiyan S Rabindranath; John B W Schollum; David J Semple; Zhengxiu Xie; Tian Min Ma; Rose Sisk; Joanna L Dunlop
Journal:  J Am Soc Nephrol       Date:  2020-03-18       Impact factor: 10.121

5.  Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass.

Authors:  Joanna Leigh Dunlop; Alain Charles Vandal; Janak Rashme de Zoysa; Ruvin Sampath Gabriel; Imad Adbi Haloob; Christopher John Hood; Philip James Matheson; David Owen Ross McGregor; Kannaiyan Samuel Rabindranath; David John Semple; Mark Roger Marshall
Journal:  BMC Nephrol       Date:  2013-07-15       Impact factor: 2.388

6.  Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial.

Authors:  Kazuomi Kario; Yoshiaki Yokoi; Keisuke Okamura; Masahiko Fujihara; Yukako Ogoyama; Eiichiro Yamamoto; Hidenori Urata; Jin-Man Cho; Chong-Jin Kim; Seung-Hyuk Choi; Keisuke Shinohara; Yasushi Mukai; Tomokazu Ikemoto; Masato Nakamura; Shuichi Seki; Satoaki Matoba; Yoshisato Shibata; Shigeo Sugawara; Kazuhiko Yumoto; Kouichi Tamura; Fumiki Yoshihara; Satoko Nakamura; Woong Chol Kang; Taro Shibasaki; Keigo Dote; Hiroyoshi Yokoi; Akiko Matsuo; Hiroshi Fujita; Toshiyuki Takahashi; Hyun-Jae Kang; Yasushi Sakata; Kazunori Horie; Naoto Inoue; Ken-Ichiro Sasaki; Takafumi Ueno; Hirofumi Tomita; Yoshihiro Morino; Yuhei Nojima; Chan Joon Kim; Tomoaki Matsumoto; Hisashi Kai; Shinsuke Nanto
Journal:  Hypertens Res       Date:  2021-10-15       Impact factor: 3.872

Review 7.  Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium.

Authors:  David E Kandzari; Felix Mahfoud; Michael A Weber; Raymond Townsend; Gianfranco Parati; Naomi D L Fisher; Melvin D Lobo; Michael Bloch; Michael Böhm; Andrew S P Sharp; Roland E Schmieder; Michel Azizi; Markus P Schlaich; Vasilios Papademetriou; Ajay J Kirtane; Joost Daemen; Atul Pathak; Christian Ukena; Philipp Lurz; Guido Grassi; Martin Myers; Aloke V Finn; Marie-Claude Morice; Roxana Mehran; Peter Jüni; Gregg W Stone; Mitchell W Krucoff; Paul K Whelton; Konstantinos Tsioufis; Donald E Cutlip; Ernest Spitzer
Journal:  Circulation       Date:  2022-03-14       Impact factor: 29.690
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.